Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease

scientific article

Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMANEUROL.2016.3232
P932PMC publication ID5195903
P698PubMed publication ID27842175

P50authorHenrik ZetterbergQ6252048
Kaj BlennowQ28321550
Sterling C. JohnsonQ51007286
Barbara B BendlinQ56849465
Cynthia M CarlssonQ114270827
Mark A SagerQ114336826
Nancy J Davenport-SisQ117234573
P2093author name stringSanjay Asthana
Douglas C Dean
Andrew L Alexander
Cristybelle Canda
J Patrick O'Grady
Samuel A Hurley
Steven R Kecskemeti
P2860cites workAlzheimer's disease as homeostatic responses to age-related myelin breakdownQ22251261
Human brain myelination and amyloid beta deposition in Alzheimer's diseaseQ22252428
“Mini-mental state”Q25938989
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeuticsQ27860914
The preclinical phase of the pathological process underlying sporadic Alzheimer's diseaseQ28083428
Brain development during childhood and adolescence: a longitudinal MRI studyQ28144698
CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's diseaseQ28728773
Characterizing longitudinal white matter development during early childhood.Q30407553
Investigating white matter development in infancy and early childhood using myelin water faction and relaxation time mappingQ30447179
One component? Two components? Three? The effect of including a nonexchanging "free" water component in multicomponent driven equilibrium single pulse observation of T1 and T2Q30558819
Advances in myelin imaging with potential clinical application to pediatric imaging.Q30610337
Insights into brain microstructure from the T2 distributionQ31039635
Gleaning multicomponent T1 and T2 information from steady-state imaging dataQ33386351
White matter in aging and cognition: a cross-sectional study of microstructure in adults aged eighteen to eighty-threeQ33956998
Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease.Q33984509
3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjectsQ33990243
Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.Q34020232
Myelin water imaging reflects clinical variability in multiple sclerosisQ34095719
Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseQ34098866
White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI.Q34356936
Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomographyQ34435040
Myelin basic protein binds to and inhibits the fibrillar assembly of Abeta42 in vitroQ35199200
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal eldersQ35231675
CSF markers for incipient Alzheimer's diseaseQ35541472
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's diseaseQ35607811
Epidemiology of Alzheimer diseaseQ35920548
In vivo visualization of myelin water in brain by magnetic resonanceQ36736879
Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathologyQ36976882
Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolismQ37189385
Degradation of amyloid beta protein by purified myelin basic proteinQ37431176
Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicineQ37835982
Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's diseaseQ40634928
Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's PreventionQ42673976
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapsesQ48130989
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.Q51944474
Cerebrospinal fluid markers for prediction of Alzheimer's diseaseQ53258455
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectpathologyQ7208
Alzheimer's diseaseQ11081
P304page(s)41-49
P577publication date2016-11-14
P1433published inJAMA NeurologyQ276813
P1476titleAssociation of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease
P478volume74

Reverse relations

cites work (P2860)
Q906443783D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice
Q58857913Alzheimer disease pathology and the cerebrospinal fluid proteome
Q92769403An emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases
Q47165802Axonal and myelinic pathology in 5xFAD Alzheimer's mouse spinal cord.
Q92572412Aβ oligomers promote oligodendrocyte differentiation and maturation via integrin β1 and Fyn kinase signaling
Q64018601Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis.
Q96816564Cellular senescence and Alzheimer disease: the egg and the chicken scenario
Q64233641Changes of Myelin Organization in Patients with Alzheimer's Disease Shown by q-Space Myelin Map Imaging
Q47651485Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases
Q90072371Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice
Q58549216Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review
Q91955237Elevated Insulin and Insulin Resistance are Associated with Altered Myelin in Cognitively Unimpaired Middle-Aged Adults
Q52572998Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content.
Q90105907Interactive effect of age and APOE-ε4 allele load on white matter myelin content in cognitively normal middle-aged subjects
Q92678237Longitudinal associations between white matter maturation and cognitive development across early childhood
Q90390163M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera
Q90587069Modeling white matter tract integrity in aging with diffusional kurtosis imaging
Q38371303Myelin content changes in probable Alzheimer's disease and mild cognitive impairment: Associations with age and severity of neuropsychiatric impairment.
Q99547354Nonlinear associations of neurite density and myelin content with age revealed using multicomponent diffusion and relaxometry magnetic resonance imaging
Q46313806Pathways to Brain Aging and Their Modifiers: Free-Radical-Induced Energetic and Neural Decline in Senescence (FRIENDS) Model - A Mini-Review
Q58598981Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors
Q88522879Prospective study of myelin water fraction changes after mild traumatic brain injury in collegiate contact sports
Q47324557Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.
Q38814687Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?
Q100766148Repeatability and reproducibility of human brain morphometry using three-dimensional magnetic resonance fingerprinting
Q89731034Systems modeling of white matter microstructural abnormalities in Alzheimer's disease
Q47646484The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
Q90447268The role of myelin damage in Alzheimer's disease pathology
Q89587833Use of the NESMA Filter to Improve Myelin Water Fraction Mapping with Brain MRI
Q92924571White Matter and Neuroprotection in Alzheimer's Dementia

Search more.